Lead identification of therapeutic anti-glycan antibodies for cancer therapy
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA186326
- Recipient
-
Siamab Therapeutics, Inc. UEI DJM5GUE2NWD7
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $219,846
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Waban, MA 02468, USA
Award details come from USAspending.gov.
Quick answers
Who received award R43CA186326?
R43CA186326 was awarded to Siamab Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on May 1, 2015.
How much is award R43CA186326 worth?
$219,846 has been obligated on R43CA186326.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award